Ascendis Health Ltd ASC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ZAC 78.00
- Day Range
- ZAC 79.00–80.00
- 52-Week Range
- ZAC 59.00–83.00
- Bid/Ask
- ZAC 78.00 / ZAC 80.00
- Market Cap
- ZAC 50.08 Bil
- Volume/Avg
- 30,100 / 129,598
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.34
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company’s revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,200
- Website
- https://www.ascendishealth.com
Valuation
|
Metric
|
ASC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.78 |
Price/Sales | 0.34 |
Price/Cash Flow | — |
Price/Earnings
ASC
Financial Strength
|
Metric
|
ASC
|
|---|---|
Quick Ratio | 0.95 |
Current Ratio | 1.87 |
Interest Coverage | — |
Quick Ratio
ASC
Profitability
|
Metric
|
ASC
|
|---|---|
Return on Assets (Normalized) | −1.38% |
Return on Equity (Normalized) | −2.53% |
Return on Invested Capital (Normalized) | −4.56% |
Return on Assets
ASC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Wrqjgttk | Klzysw | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Kxctdwrh | Klz | $68.9 Bil | |
HLN
| Haleon PLC ADR | Ygswdnb | Pkj | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jlrzcmmh | Ktdn | $14.7 Bil | |
VTRS
| Viatris Inc | Brpkgfcj | Vdqd | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zybzttcvq | Hhgz | $11.9 Bil | |
CTLT
| Catalent Inc | Stvhxsb | Zzlwkw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nrphqtnyb | Jfn | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Gdgmzycdl | Mqmj | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vdjfbzb | Cxjynsy | $3.5 Bil |